Andy Plant
President, R&D
Replay available
Takeda Pharmaceutical Company Limited (TAK) Q4 2025 Earnings Call
Takeda Pharmaceutical Company Limited (NYSE: TAK) Q4 2025 earnings conference call, held 2026-05-13. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Milano Furuta
Chief Financial Officer
Ronda Pacheco
President, U.S. Business Unit
Julie Kim
CEO-elect, President & CEO-designate
Mike Nedeljkovic
Analyst, TD Cowen
Tony Ren
Analyst, Macquarie
Christophe Weber
President & CEO
Steve Barker
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Takeda Pharmaceutical Co. Ltd..
Replay transcript excerpt
WEBVTT 00:00:00.554 -- 00:00:01.997 Thank 00:00:01.997 -- 00:00:06.766 you very much for joining FY2025Q4 00:00:06.766 -- 00:00:08.188 Learning 00:00:08.188 -- 00:00:14.260 School for Takeda Pharmaceutical Company. An O'Reilly 00:00:14.260 -- 00:00:16.384 IR head, 00:00:16.384 -- 00:00:18.247 I will serve as MC. 00:00:18.247 -- 00:00:20.989 First, language 00:00:21.654 -- 00:00:23.654 setting. 00:00:24.500 -- 00:00:27.682 For those 00:00:28.967 -- 00:00:30.967 of 00:00:32.132 -- 00:00:34.977 you who wish 00:00:34.977 -- 00:00:40.406 to listen to this call in English, please select English 00:00:40.406 -- 00:00:43.708 in the Zoom language select button. 00:00:46.623 -- 00:00:48.623 Before 00:00:49.567 -- 00:00:54.674 starting, I'd like to remind everyone that we will be 00:00:54.674 -- 00:01:00.102 discussing forward-looking statements within the meaning of the Private Securities 00:01:00.102 -- 00:01:05.149 Litigation Reform Act of 1995. Actual results made different materially from those 00:01:05.149 -- 00:01:10.664 discussed today. The factors that could cause actual results to differ materially 00:01:10.664 -- 00:01:16.261 are discussed in our most recent Form 20F and in our other SEC 00:01:16.261 -- 00:01:18.261 findings. 00:01:20.491 -- 00:01:22.491 And 00:01:24.697 -- 00:01:28.103 please also refer to the important notice of page 2. 00:01:28.103 -- 00:01:31.989 We may also refer to non-IFRS 00:01:31.989 -- 00:01:38.158 financial numbers for the definition and consultation. 00:01:38.158 -- 00:01:41.723 Please refer to the appendix in the presentation. 00:01:41.723 -- 00:01:43.706 Now 00:01:43.706 -- 00:01:47.088 let's start today's presentation. 00:01:47.778 -- 00:01:49.778 President 00:01:49.780 -- 00:01:54.965 and CEO Christoph Weber, CEO-elect Juleke, Chief 0...